POINT Biopharma Global
Stock Forecast, Prediction & Price Target
POINT Biopharma Global Financial Estimates
POINT Biopharma Global Revenue Estimates
POINT Biopharma Global EBITDA Estimates
POINT Biopharma Global Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $226.57M 0% | Avg: $218.98M Low: $45.73M High: $428.68M avg. -3.35% | |||
Net Income
% change YoY
| $-13.37M N/A | $-45.90M -243.24% | $98.29M 314.13% | Avg: $37.41M Low: $-147.89M High: $139.25M avg. -61.93% | |||
EBITDA
% change YoY
| $-13.11M N/A | $-45.51M -247.02% | $127.32M 379.75% | Avg: $187.01M Low: $39.05M High: $366.08M avg. 46.87% | |||
EPS
% change YoY
| -$0.34 N/A | -$0.62 -82.35% | $1.04 267.74% | Avg: $0.24 Low: -$1.54 High: $1.45 avg. -77.06% | |||
Operating Expenses
% change YoY
| $13.11M N/A | $45.51M 247.02% | $101.05M 122.04% | Avg: $152.11M Low: $31.76M High: $297.77M avg. 50.52% | |||
FAQ
What is POINT Biopharma Global stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -61.93% in 2025-2025.
We have gathered data from 7 analysts. Their low estimate is -147.89M, average is 37.41M and high is 139.25M.
What is POINT Biopharma Global stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -3.35% in 2025-2025.
We have gathered data from 8 analysts. Their low revenue estimate is $45.73M, average is $218.98M and high is $428.68M.
What is POINT Biopharma Global stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -77.06% in 2025-2025.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$1.54, average is $0.24 and high is $1.45.
What is the best performing analyst?
In the last twelve months analysts have been covering POINT Biopharma Global stock. The most successful analyst is Edward Tenthoff.